Bevacizumab and Tocotrienol in Recurrent Ovarian Cancer

Clinical trial NCT04175470 · COMPLETED

Trial details

NCT number: NCT04175470
Sponsor: Vejle Hospital
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Recurrent

Start date: 2019-10-29
Primary completion: 2024-07-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.